⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 20, 2024Substance Use & MisuseOpen Access

Long-Acting Injectable Buprenorphine for Opioid Use Disorder: A Qualitative Analysis of Patients’ Interpersonal Relationships during the First Year of Treatment

Joanne Neale John Strang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Long-acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder. Drawing upon new materialism and the concept of social capital, this article provides a focused analysis of how LAIB affects, and is affected by, patients' relationships with other people.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Neale et al. (2024) studied this question.

synapsesocial.com/papers/68e5b8a1b6db6435875513e7 https://doi.org/10.1080/10826084.2024.2392553

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Long-acting injectable buprenorphine in the real world: case report on dual disorders2024 · 3 citations
2Employment and Long-Acting Injectable Buprenorphine for Opioid Use Disorder: Findings from Longitudinal Qualitative Interviews Conducted with Patients Recruited from Drug Treatment Services2025 · 2 citations
3More Than a Medication: The Lived Meaning and Value of Long-Acting Injectable Buprenorphine.Original Research · 2026 · 2 citations
4Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (LAIB) for the Treatment of Opioid Use Disorder: A Series of Narrative InterviewsOriginal Research · 2026 · 1 citations
5Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study2024 · 12 citations